as on October 17, 2025 at 1:29 am IST
Day's Low
Day's High
2.61%
Downside
0.56%
Upside
52 Week's Low
52 Week's High
36.92%
Downside
42.35%
Upside
Check Mannkind Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.6B
EPS (TTM)
0.2
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.09%
PE Ratio (TTM)
47.55
Industry PE ratio
-0.32286624203821657
PEG Ratio
-0.23
EBITDA
81.2M
Revenue (TTM)
301.7M
Profit Margin
10.87%
Return On Equity TTM
0.00%
Track how Mannkind Corp. P/E has moved over time to understand its valuation trends.
Mannkind Corp. in the last 5 years
Lowest (-83.58x)
December 31, 2023
Industry (-0.32x)
October 17, 2025
Today (47.55x)
October 17, 2025
Highest (114.51x)
March 31, 2024
Today’s Price to Earnings Ratio: 47.55x
Compare market cap, revenue, PE, and other key metrics of Mannkind Corp. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.6B | 167.5% | 47.55 | 10.87% | |
BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
NA | $35.8B | NA | NA | -3.89% | |
BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
BUY | $61.1B | -5.1% | 14.53 | 31.37% |
The Mannkind Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Mannkind Corp. investment value today
Current value as on today
₹85,859
Returns
Returns from Mannkind Corp. Stock
Dollar Returns*
₹4,647 (+4.65%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Mannkind Corp.. Average target price of $10.38
Get share price movements and forecasts by analysts on Mannkind Corp..
What analysts predicted
48.36%UPSIDE
Target Price
$10.38
Current Price
$5.36
Analyzed by
12 Analysts
Target
$10.38
Mannkind Corp. target price $10.38, a slight upside of 48.36% compared to current price of $5.36. According to 12 analysts rating.
Search interest for Mannkind Corp. Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, MNKD stock has moved up by 9.6%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 81.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 83.0%
Profit Down
Netprofit is down for the last 2 quarters, 13.15M → 668.0K (in $), with an average decrease of 94.9% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 78.35M → 76.52M (in $), with an average decrease of 2.3% per quarter
Organisation | Mannkind Corp. |
Headquarters | 1 Casper Street, Danbury, CT, United States, 06810 |
Industry | Health Technology |
CEO | Dr. Michael E. Castagna Pharm.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. David B. Thomson J.D., Ph.D. | Executive VP, General Counsel & Secretary |
Mr. Sanjay Singh M.B.A. | Executive Vice President of Technical Operations |
Ms. Rosabel Realica Alinaya CPA | VP of Investor Relations & Treasury |
Dr. Stuart A. Tross Ph.D. | Executive Vice President of Human Resources |
Mr. John F. Bedard | Senior Vice President of Worldwide Regulatory Affairs |
Dr. Kevin Kaiserman M.D. | Senior VP & Therapeutic Area Head of Endocrine Diseases |
Mr. Dominic Marasco R.Ph. | President of Endocrine Business Unit |
Mr. Christopher B. Prentiss M.B.A. | Chief Financial Officer |
Dr. Ajay Ahuja M.B.A., M.D. | Chief Medical Officer |
Dr. Michael E. Castagna Pharm.D. | CEO & Director |
Mannkind Corp. share price today is $5.36 as on at the close of the market. Mannkind Corp. share today touched a day high of $5.39 and a low of $5.22.
Mannkind Corp. share touched a 52 week high of $7.63 on and a 52 week low of $3.38 on . Mannkind Corp. stock price today i.e. is closed at $5.36,which is 29.75% down from its 52 week high and 58.52% up from its 52 week low.
Mannkind Corp. market capitalisation is $0.00T as on .
Indian investors can start investing in Mannkind Corp. (MNKD) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Mannkind Corp. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mannkind Corp. share’s latest price of $5.36 as on October 17, 2025 at 1:29 am IST, you will get 1.8657 shares of Mannkind Corp.. Learn more about
fractional shares .
Mannkind Corp. stock has given 167.5% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?